Cargando…
ADAM metalloproteases and EGFR signalling
Autores principales: | Gee, Julia MW, Knowlden, Janice M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314437/ https://www.ncbi.nlm.nih.gov/pubmed/12927027 |
Ejemplares similares
-
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004) -
Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors
por: Gee, Julia MW
Publicado: (2002) -
Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models
por: Gee, Julia MW, et al.
Publicado: (2005) -
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
por: Giebeler, Nives, et al.
Publicado: (2016) -
A Disintegrin and Metalloproteases (ADAMs): Activation, Regulation and Mechanisms of Catalysis
por: Maretzky, Thorsten
Publicado: (2021)